🇺🇸 FDA
Patent

US 9175003

Substituted azoanthracene derivatives and intermediates for preparation thereof

granted A61PA61P13/12A61P17/02

Quick answer

US patent 9175003 (Substituted azoanthracene derivatives and intermediates for preparation thereof) held by VTV THERAPEUTICS LLC expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VTV THERAPEUTICS LLC
Grant date
Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P13/12, A61P17/02, A61P25/02, A61P27/02